HMT advised Bay Tree Private Equity on their investment in Medicare Insourcing Services Limited, a leading provider of clinical insourcing services to the NHS.
Founded in 2018, Medicare is a leading provider of clinical insourcing services to the NHS, specialising in practitioner-led diagnostic imaging, primarily ultrasound. The business partners with NHS Trusts to deliver additional capacity within hospital settings, helping reduce waiting lists and improve patient outcomes.
Medicare has built a strong national footprint, supported by a high-quality network of advanced practitioners and a reputation for consistent clinical delivery.
As part of the transaction, Stephen Collier has been appointed as Chair. Stephen brings significant experience of supporting and scaling healthcare services businesses and will work closely with the management team and Bay Tree to support the next phase of growth.
HMT undertook financial due diligence on this transaction.
“The HMT team were a true partner in getting this deal done. Paul, Corin and Oliver combined rigorous analysis with real commercial insight, surfacing key risks early and validating the upside with clarity. Their responsiveness and ability to translate complex findings into actionable recommendations gave us real confidence in our decision-making.”
– Ed Cottrell, Partner – Bay Tree
“We are delighted to have advised Bay Tree on their investment in Medicare. The business operates in a structurally attractive market and Bay Tree’s investment will support Medicare’s next phase of growth, including expanding its clinician network, deepening NHS Trust relationships and developing adjacent diagnostic services. We look forward to working with them again in the future.”
– Paul Read
